- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Arihant Capital Markets secured 'no adverse observations' from BSE and 'no-objection' from NSE for its Composite Scheme of Arrangement. This clears a key hurdle for the company's multi-entity restructuring plan, pending final approvals.